WHO gives Sinovac the all-clear

The leading public health authority, the World Health Organisation (WHO), has officially approved the Chinese-developed Sinovac Biotech Covid vaccine. The vaccine, which has seen use in more than 30 countries, received the WHO’s emergency use status last Tuesday. This means it can now be considered by COVAX, the global body tasked with ensuring fair and…

Chinese Covid vaccine wins patent approval

Tianjin-based vaccine producer, CanSino Biologics, has won patent approval for its Ad5-nCOV vaccine candidate. The Covid-19 vaccine was approved in Beijing on 11 August, Chinese state-owned media reported citing documents released by China’s Intellectual Property Administration. The Ad5-nCOV candidate was co-developed by CanSino Biologics and a team of infectious disease experts, led by Chen Wei,…